WHC is still in active development. Read this to understand our approach.
depiction of GLUUGHFHXGJENI-UHFFFAOYSA-N.svg
isomerdesign

Piperazine

Check on isomerdesign

pubchem

Piperazine

Check on pubchem

drugmap

Piperazine

Check on drugmap

Data

InChI: InChI=1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2

Synonyms: NCIOpen2_005072, Piperazin, Dispermine,CCRIS 5950,Piperazine-[U-2,3,5,6-13C4],D00807,FEMA NO. 4250,KBio2_004161,DSSTox_RID_75986,Piperazine, anhydrous,PIPERAZINE [MART.],P02CB01,P0447, 1,4-Diazacyclohexane,Anthalazine,PIPERAZINE [II],NCIOpen2_005145,AB00052073_03,PIPERAZINE [MI],NCIOpen2_004910, Worm-away,Piperazine-[U-13C4] dihydrochloride,SBI-0051485.P003,NCIOpen2_000984, Hexahydropyrazine,NCIOpen2_001262,NCIOpen2_005032,PIPERAZINUM,KBio2_001593,SPECTRUM1500490, Eraverm (VAN),NCGC00094762-08,Piperazin [German],Lumbrical, Vermizine (TN),Pipersol, Piperazine [USAN],PIPERAZINE [FHFI],ACT02177, Piperazidine,NCIOpen2_005108,Piperazine, BioUltra, anhydrous, >=99.0% (T), Pyrazine hexahydride,CCG-212753,Spectrum_001113,DivK1c_000038,TRIMETAZIDINE DIHYDROCHLORIDE IMPURITY G [EP IMPURITY],1,4-Diethylenediamine,Tox21_300104, Piperazine, anhydrous,Vermex,SR-05000001700,NCIOpen2_005185,NCIOpen2_005022,s4574,Vermizine (TN),Piperazin [Germany],Tasnon (Salt/Mix), Hexahydro-1,4-diazine,Piperazin,DSSTox_CID_1164,BRN 0102555,110-85-0,525586-93-0,PIPERAZINE [GREEN BOOK],NCGC00259791-01,Q-201586,Vermizine (Salt/Mix),Worm-A-Ton,Piperazine anhydrous, Lumbrical,Piperazine, anhydrous, >=99.0% (T),4-diazacyclohexane,NCIOpen2_004982,NCIOpen2_001071,Piperazidine,NCIOpen2_005102, Worm-A-Ton, Piperazine [UN2579] [Corrosive],NSC 474, LTBB000432,HMS2092A03, Vermex,UNII-1RTM4PAL0V,NCIOpen2_001031,piperzine,FT-0673919,LF-0561,NCGC00094762-05,NSC757283,NCIOpen2_004954,NCIOpen2_005575, Diethyleneimine,NCIOpen2_005062,Z1245537944,NCIOpen2_004904, Diethylenediamine,NCIOpen2_004830,NCIOpen2_004834,F0001-0226,NCIOpen2_001111,NCIOpen2_005187,Piperazine [USP],NCIOpen2_001231,PIPERAZINE [USP MONOGRAPH],NCIOpen2_005182,NCIOpen2_004952,NCIOpen2_009422,NCIOpen2_001033,Diethyleneimine,Piperazine, analytical standard,EINECS 203-808-3,Piperazine [UN2579] [Corrosive],NCIOpen2_004874,HMS500B20,1,4-Diazacyclohexane, Asca-Trol No. 3,Piperazine, p.a., 98%,5-23-01-00030 (Beilstein Handbook Reference),DB00592,Piperazine, homopolymer,NCGC00094762-02,Piperazine, ReagentPlus(R), 99%,CHEMBL1412, 1,4-Piperazine, Eraverm,piperazine,CS-4381,NCGC00094762-01, Wurmirazin,NCIOpen2_005034,Asca-Trol No. 3,1RTM4PAL0V,UN2579,BIDD:GT0273, PIPERAZINE (HEXAHYDRATE),NCIOpen2_001073, Piperazinium oleate,STL169348,C07973,Piperazine, United States Pharmacopeia (USP) Reference Standard,Hexahydropyrazine, Antiren, Uvilon, Piperazin [Germany],Antiren,PIPERAZINE [HSDB],NCIOpen2_004942,Tox21_202242,EN300-33920,Spectrum5_001817,31977-51-2,NCGC00254077-01, Piperazine (USP),piprazine,AKOS000269028,BCP24060,Eraverm,DSSTox_GSID_21164, Piperazin [German],1,4-Piperazine,Uvilon, Vermizine,Diethylenediamine,IDI1_000038,MFCD00005953,Pyrazine hexahydride,NCIOpen2_001269,PIPERAZINE [VANDF],KBioSS_001593,Upixon,PIPERAZINE [USP-RS], Pipersol,Pyrazine, hexahydro-, Piperazine anhydrous,NCIOpen2_001024,Piperazine, 99%,Hexahydro-1,4-diazine,7-piperazine,Piperazine,HMS3885L08, Piperazine Dihydrochloride Dihydrochloride Hydrate,Q409292,PZE,NSC-474,Piperazine-,Vermidol (Salt/Mix),PIPERAZINE [WHO-DD],STR00051,NINDS_000038,piperizine,CHEBI:28568,WLN: T6M DMTJ,HMS1920H20, PZE,NCIOpen2_005980,Piperazine (USP),NCGC00094762-03, Upixon,Exelmin (Salt/Mix),Pharmakon1600-01500490,KBio1_000038,HY-B0912,EC 203-808-3,NCGC00094762-04,Dispermine,CAS-110-85-0,ZINC5850277,NSC474, Piperazine Hexa-Hydrate,NCIOpen2_001151,NSC-757283,Tox21_113564,HSDB 1093,NCIOpen2_005200,NCIOpen2_000988,1323940-30-2,KBio2_006729,NCIOpen2_004914,SR-05000001700-1,Eraverm (VAN),NCIOpen2_004994,PIPERAZINUM [HPUS],NCIOpen2_004862,exahydropyrazine, Pyrazine, hexahy, 1,4-Diethylenediamine,NCIOpen2_004992,P0446,DTXSID1021164,UN 2579,Wurmirazin


Estimated data

Solubility: 1.181 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 63.6% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.